← Leaderboards
Ralph S Freedman
University Of Texas Hlth Sci Ctr Houston
$885,116
Attributed
$885,116
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$885,116 · 4
By mechanism
R21$870,016 · 2
M01$15,100 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Sunil Krishnan$6,566,279
- Eugenie S Kleinerman$6,577,718
- John Duffin Reveille$11,528,689
- Renato Lenzi$48,935
- Chunlin Qin$6,633,046
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectNeoplasm /Cancer ImmunotherapyHuman Therapy EvaluationOvary NeoplasmsIntraperitoneal InjectionsClinical ResearchInterferon GammaNeoplasm /Cancer VaccineCytotoxic T LymphocyteNeoplasm /Cancer ImmunologyVaccine DevelopmentInterleukin 12Patient Oriented ResearchVector VaccineDrug Adverse EffectEnzyme Linked Immunosorbent AssayFibroblast Growth FactorInterleukin 10Interleukin 2Interleukin 5Interleukin 8Leukocyte Activation /TransformationMinimal Residual DiseasePharmacokinetics
Grant awards (6)
Autologous therapeutic tumor vaccine + IFN-gamma$3,972
M01 · FY2004 · RR
Phase ii intraperitoneal rhIL 12$270,000
R21 · FY2002 · CA
Phase ii intraperitoneal rhIL 12$307,500
R21 · FY2001 · CA
B7.1 COSTIMULATION IN OVARIAN CANCER$148,386
R21 · FY2001 · CA
B7.1 COSTIMULATION IN OVARIAN CANCER$144,130
R21 · FY2000 · CA
AUTOLOGOUS THERAPEUTIC TUMOR VACCINE + IFN GAMMA IN OVARIAN CANCER$11,128
M01 · FY2000 · RR